Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Antitumor effects of 4-methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 140, Issue 2, Pages 469-479
Publisher
Wiley
Online
2016-10-13
DOI
10.1002/ijc.30460
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 4-Methylumbelliferone Treatment and Hyaluronan Inhibition as a Therapeutic Strategy in Inflammation, Autoimmunity, and Cancer
- (2015) Nadine Nagy et al. Frontiers in Immunology
- Hyaluronan expression as a significant prognostic factor in patients with malignant peripheral nerve sheath tumors
- (2014) Kunihiro Ikuta et al. CLINICAL & EXPERIMENTAL METASTASIS
- Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial
- (2014) Ian Judson et al. LANCET ONCOLOGY
- Sirolimus for progressive neurofibromatosis type 1-associated plexiform neurofibromas: a Neurofibromatosis Clinical Trials Consortium phase II study
- (2014) B. Weiss et al. NEURO-ONCOLOGY
- 4-Methylumbelliferone inhibits ovarian cancer growth by suppressing thymidine phosphorylase expression
- (2014) Ryosuke Tamura et al. Journal of Ovarian Research
- Imatinib mesylate inhibits cell growth of malignant peripheral nerve sheath tumors in vitro and in vivothrough suppression of PDGFR-β
- (2013) Jun Ohishi et al. BMC CANCER
- Hyaluronan synthesis inhibitor supplements the inhibitory effects of zoledronic acid on bone metastasis of lung cancer
- (2013) Naohisa Futamura et al. CLINICAL & EXPERIMENTAL METASTASIS
- Prognostic Significance of AKT/mTOR and MAPK Pathways and Antitumor Effect of mTOR Inhibitor in NF1-Related and Sporadic Malignant Peripheral Nerve Sheath Tumors
- (2012) M. Endo et al. CLINICAL CANCER RESEARCH
- Inhibition of hyaluronan retention by 4-methylumbelliferone suppresses osteosarcoma cells in vitro and lung metastasis in vivo
- (2011) E Arai et al. BRITISH JOURNAL OF CANCER
- Inhibition of hyaluronan synthesis in breast cancer cells by 4-methylumbelliferone suppresses tumorigenicity in vitro and metastatic lesions of bone in vivo
- (2011) Hiroshi Urakawa et al. INTERNATIONAL JOURNAL OF CANCER
- First-line chemotherapy for malignant peripheral nerve sheath tumor (MPNST) versus other histological soft tissue sarcoma subtypes and as a prognostic factor for MPNST: an EORTC Soft Tissue and Bone Sarcoma Group study
- (2010) J. R. Kroep et al. ANNALS OF ONCOLOGY
- 4-Methylumbelliferone inhibits tumour cell growth and the activation of stromal hyaluronan synthesis by melanoma cell-derived factors
- (2010) M. Edward et al. BRITISH JOURNAL OF DERMATOLOGY
- Antitumor Activity of Hyaluronic Acid Synthesis Inhibitor 4-Methylumbelliferone in Prostate Cancer Cells
- (2010) Vinata B. Lokeshwar et al. CANCER RESEARCH
- Deficiency in the Serum-Derived Hyaluronan-Associated Protein-Hyaluronan Complex Enhances Airway Hyperresponsiveness in a Murine Model of Asthma
- (2010) Long Zhu et al. INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
- Abrogating Drug Resistance in Malignant Peripheral Nerve Sheath Tumors by Disrupting Hyaluronan-CD44 Interactions with Small Hyaluronan Oligosaccharides
- (2009) M. G. Slomiany et al. CANCER RESEARCH
- 4-Methylumbelliferone inhibits hyaluronan synthesis by depletion of cellular UDP-glucuronic acid and downregulation of hyaluronan synthase 2 and 3
- (2009) Anne Kultti et al. EXPERIMENTAL CELL RESEARCH
- Malignant peripheral nerve sheath tumour (MPNST): the clinical implications of cellular signalling pathways
- (2009) Daniela Katz et al. EXPERT REVIEWS IN MOLECULAR MEDICINE
- Preclinicalin vivoevaluation of rapamycin in human malignant peripheral nerve sheath explant xenograft
- (2009) Priya Bhola et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Multicenter Trial of Imatinib in 10 Histologic Subtypes of Sarcoma Using a Bayesian Hierarchical Statistical Model
- (2009) Rashmi Chugh et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Sorafenib in Patients With Metastatic or Recurrent Sarcomas
- (2009) Robert G. Maki et al. JOURNAL OF CLINICAL ONCOLOGY
- Induction of Apoptosis in Neurofibromatosis Type 1 Malignant Peripheral Nerve Sheath Tumor Cell Lines by a Combination of Novel Farnesyl Transferase Inhibitors and Lovastatin
- (2008) J. W. Wojtkowiak et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells
- (2008) G. Ambrosini et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now